We are live on
!
Find out more
HCM
Horton Capital Management Portfolio holdings
AUM
$44.9M
1-Year Est. Return
24.87%
This Fund
S&P 500
This Quarter
Est. Return
+6.43%
1 Year Est. Return
-24.87%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$106M
AUM Growth
+$3.08M
(+3%)
Cap. Flow
+$3.4M
Cap. Flow
% of AUM
3.21%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
2
Reduced
1
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UroGen Pharma
URGN
|
+$3.86M |
| 2 |
CTEK
CynergisTek, Inc.
CTEK
|
+$375K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KORU Medical Systems
KRMD
|
+$839K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 90.61% |
| 2 | Financials | 5.66% |
| 3 | Technology | 2.45% |
| 4 | Industrials | 1.27% |
Similar funds
NCP
CO
IP
HR
WLRC
HCIL
AC
BBCM
Horton Capital Management's Q1 2020 Portfolio in Review
As of Q1 2020, Horton Capital Management held 7 positions worth $106M, up 3% from $103M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Horton Capital Management deployed $3.4M of net new capital in Q1 2020, adding to 2 existing holdings.
By sector, the portfolio is most concentrated in Healthcare at 91% of assets, up from 82% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was KORU Medical Systems, an estimated $839K trimmed.
- Horton Capital Management added most to UroGen Pharma in Q1 2020, an estimated $3.86M increase.
- Horton Capital Management's biggest Q1 2020 reduction was KORU Medical Systems, cutting an estimated $839K.
- Horton Capital Management's ten largest holdings make up 100% of its $106M portfolio in Q1 2020.
- Horton Capital Management opened 0 new positions and closed 0 in Q1 2020.
- Horton Capital Management's portfolio value rose 3% quarter-over-quarter to $106M.
Based on Horton Capital Management's 13F filing for Q1 2020, filed 27 Apr 2020.